background prior mention zyprexa allegedly marketed label treatment dementia including writing alex berenson post provide details regarding issue especially hypothetical case martha case used lilly sales representatives meetings physicians reading piece please note lilly denied markets products label martha symptoms described much strongly resembling dementia either schizophrenia bipolar two indications zyprexa fda approved according alex berenson martha described widow adult children lives independently patient time martha described agitated disturbed sleep without symptoms paranoia mania typically marked person schizophrenia bipolar disorder berenson noted lilly spokesperson said martha intended represent patient schizophrenia martha martha perhaps document examined berenson document titled zyprexa olanzapine primary care implementation guide dated june martha martha widow lives independently patient time becoming complicated manage note increasing agitation sleep disturbed dozes day night family shared concerns saying thinks trying take advantage martha family want send nursing home agitation confusion must addressed goals treatment martha may include reducing behavioral disturbances without impairing cognitive functioning martha schizophrenia upon checking diagnostic statistical manual mental disorders fourth edition text revision dsm iv tr criteria schizophrenia appears martha meet diagnostic criteria schizophrenia despite lilly claims martha intended represent patient schizophrenia later document discusses possible zyprexa dosage martha starting dose mg even mg bedtime appropriate schizophrenia trials zyprexa typically dosed mg mg mg also apparently contradicts lilly claim intending martha represent patient schizophrenia would make little sense lilly recommend subtherapeutic dose zyprexa physicians heading back cover close stated summary doctor prescribing zyprexa safe proven solution patients like martha michael kelly suffer mood thought behavioral disturbances easy use works emphasis original note broad terminology rather discussing bipolar disorder schizophrenia zyprexa indicated language mood thought behavioral disturbances place suggests much broader application zyprexa document potential question reps may receive doctors mentioned martha i would prescribe cholinesterase inhibitor aricept supposed pretty good agitation rep prescribe zyprexa proven efficacy agitation related behavioral disturbances emphasis market years helped million patients symptoms like martha case martha note schizophrenia mentioned instead agitation related behavioral disturbances brought fore fda indication dementia document heading helpful hints subheading titled martha spread stated note right hand side spread cognition information space intentionally left open upon launch im intramuscular formulation zyprexa placing sticker spot announce new formulation new indication agitation associated dementia emphasis zyprexa never approved fda treatment dementia though would appear quote lilly expecting approval email message shed light possible label promotion zyprexa dementia documents reviewed including email issued area zyprexa champions since diagnosis patients zyprexa core message piece martha dementia emphasis enlighten little dementia know describe symptoms stay away diagnoses background elaborate dementia getting little grief docs promoting zyprexa dementia emphasis according slides audioconference set fda approved drug dementia email clearly indicates least individuals lilly seeing martha case dementia doctors seemed upset zyprexa promoted dementia martha symptoms increase ages another document titled zyprexa retail implementation guide states heading sales call subheading patient profile martha widow known treated several years aged become complicated manage clinically home comments hear family read testimonials profile main goal treatment treat illness reduce behavioral disturbances see patients like martha comment becoming complicated manage grown older sounds much reminiscent dementia schizophrenia schizophrenia symptom severity often rather clear relatively young age twenties thirties necessarily worsen time summary told documents i reviewed appear paint picture martha described patient dementia case apparently described physicians primary care settings attempt open minds prescribing zyprexa martha symptoms seem related schizophrenia rather seem strongly resemble symptoms dementia addition email indicated least lilly employees thought martha patient dementia physicians upset perceived zyprexa marketed dementia story zyprexa marketing please see following disclaimer please note i equipped state whether lilly marketing practices regarding zyprexa illegal law seems pretty unclear point course whether practice legal whether ethical two different things